BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sees Large Volume Increase – Still a Buy?

BlackRock Capital Allocation Term Trust (NYSE:BCAT) saw unusually-high trading volume on Friday . Approximately 214,058 shares changed hands during trading, a decline of 39% from the previous session’s volume of 352,540 shares.The stock last traded at $16.36 and had previously closed at $16.18.

BlackRock Capital Allocation Term Trust Trading Up 0.6 %

The firm has a fifty day simple moving average of $16.23 and a 200-day simple moving average of $16.32.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently announced a monthly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be given a $0.2885 dividend. This is a positive change from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. The ex-dividend date is Friday, November 15th. This represents a $3.46 annualized dividend and a dividend yield of 21.28%.

Insider Transactions at BlackRock Capital Allocation Term Trust

In related news, major shareholder Saba Capital Management, L.P. sold 40,158 shares of the business’s stock in a transaction that occurred on Wednesday, October 16th. The stock was sold at an average price of $16.27, for a total transaction of $653,370.66. Following the completion of the transaction, the insider now owns 14,969,295 shares in the company, valued at $243,550,429.65. The trade was a 0.27 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In the last quarter, insiders sold 723,927 shares of company stock worth $11,925,047.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Penserra Capital Management LLC acquired a new position in BlackRock Capital Allocation Term Trust during the 3rd quarter valued at approximately $15,901,000. Sanctuary Advisors LLC acquired a new position in BlackRock Capital Allocation Term Trust during the 2nd quarter valued at approximately $2,967,000. Cambridge Investment Research Advisors Inc. boosted its position in BlackRock Capital Allocation Term Trust by 4.3% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 133,238 shares of the company’s stock valued at $2,186,000 after purchasing an additional 5,438 shares during the period. Blue Bell Private Wealth Management LLC boosted its position in BlackRock Capital Allocation Term Trust by 4.0% during the 2nd quarter. Blue Bell Private Wealth Management LLC now owns 104,722 shares of the company’s stock valued at $1,718,000 after purchasing an additional 4,059 shares during the period. Finally, Mathes Company Inc. boosted its position in BlackRock Capital Allocation Term Trust by 6.0% during the 3rd quarter. Mathes Company Inc. now owns 96,500 shares of the company’s stock valued at $1,587,000 after purchasing an additional 5,500 shares during the period. Institutional investors and hedge funds own 36.12% of the company’s stock.

About BlackRock Capital Allocation Term Trust

–